An HPLC-UV method was developed for the standardization of BV in light of simultaneous quantitative estimation of Bacoside A<sub>3sub> and Piperine, the major constituents of B.聽monnieri L. and P.聽longum L. respectively. The developed method was validated on parameters including linearity, precision, accuracy and robustness.
The HPLC analysis showed significant increase in amount of Bacoside A<sub>3sub> and Piperine in the in-house sample of BV when compared with all three different marketed samples of the same. Results showed variations in the amount of Bacoside A<sub>3sub> and Piperine in different samples which indicate non-uniformity in their quality which will lead to difference in their therapeutic effects.
The outcome of the present investigation underlines the importance of standardization of Ayurvedic formulations. The developed method may be further used to standardize other samples of BV or other formulations containing Bacoside A<sub>3sub> and Piperine.